OCTREOTIDE FOR INJECTABLE SUSPENSION

Google image searchProduct monograph

Active ingredient

octreotide (octreotide acetate), 30 MG/VIAL

DIN: 02503786

Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT

Route(s) of administration: INTRAMUSCULAR

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 09-AUG-2021

ATC:

• H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
• H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
• H01CB — Antigrowth hormones (ATC, ATC/DDD)
• H01CB02 — OCTREOTIDE (ATC/DDD)

Reference brand drug: Sandostatin

External Links for Octreotide For Injectable Suspension

Search on Google

• Octreotide For Injectable Suspension side effects
• Octreotide For Injectable Suspension dosage
• octreotide side effects
• octreotide dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find octreotide for injectable suspension photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.